Non Small Cell Lung Cancer
Showing NaN - NaN of 51
Colorectal Cancer Metastatic, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in Canada, United States (EDP1503,
Completed
- Colorectal Cancer Metastatic
- +6 more
- EDP1503
- Pembrolizumab
-
Rogers, Arkansas
- +7 more
Nov 11, 2021
Non Small Cell Lung Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma Trial in Australia, United States (GRT-C901,
Active, not recruiting
- Non Small Cell Lung Cancer
- +3 more
- GRT-C901
- +3 more
-
Phoenix, Arizona
- +10 more
Aug 31, 2021
Non Small Cell Lung Cancer Trial in United States (Pegilodecakin, Pembrolizumab)
Terminated
- Non Small Cell Lung Cancer
- Pegilodecakin
- Pembrolizumab
-
Huntsville, Alabama
- +73 more
Jan 15, 2021
Circulating Tumor DNA From LIquid Biopsy in Early Stage NSCLC
Terminated
- Non Small Cell Lung Cancer
- biospecimen collection
-
Atlanta, Georgia
- +5 more
Nov 18, 2020
A Study of Personalized Neoantigen Cancer Vaccines
Completed
- Non Small Cell Lung Cancer
- +4 more
- Blood collection for research (next-generation sequencing [NGS])
- Blood collection for research (HLA typing)
-
Chicago, Illinois
- +4 more
Sep 10, 2020
Non Small Cell Lung Cancer Trial in United States (BKM120 and Erlotinib)
Completed
- Non Small Cell Lung Cancer
- BKM120 and Erlotinib
-
Fort Myers, Florida
- +6 more
Feb 25, 2019
NSCLC, Non Small Cell Lung Cancer Trial in Worldwide (OSI-906, Erlotinib, Placebo)
Completed
- NSCLC
- Non Small Cell Lung Cancer
- OSI-906
- +2 more
-
La Jolla, California
- +28 more
Jan 21, 2019
Lung Cancer, Non Small Cell Lung Cancer Trial in United States (vandetanib induction, Docetaxel, Carboplatin)
Completed
- Lung Cancer
- Non Small Cell Lung Cancer
- vandetanib induction
- +4 more
-
Boca Raton, Florida
- +29 more
Apr 30, 2018
Non Small Cell Lung Cancer Trial in Worldwide (Vandetanib, Erlotinib)
Completed
- Non Small Cell Lung Cancer
-
Berkeley, California
- +152 more
Jan 24, 2018
Non Small Cell Lung Cancer, Lung Cancer Trial in United States (defactinib (VS-6063))
Completed
- Non Small Cell Lung Cancer
- Lung Cancer
- defactinib (VS-6063)
-
Denver, Colorado
- +8 more
Apr 12, 2017
Locally Advanced Solid Tumor, Metastatic Solid Tumor, Breast Cancer Trial in Italy, Spain, United States (MSC1936369B
Completed
- Locally Advanced Solid Tumor
- +5 more
- MSC1936369B (pimasertib)
- SAR245409 (PI3K and mTOR inhibitor)
-
Scottsdale, Arizona
- +7 more
Jan 17, 2017
Non Small Cell Lung Cancer Trial in United States (Pemetrexed, Carboplatin)
Completed
- Non Small Cell Lung Cancer
-
Fort Myers, Florida
- +11 more
Jan 5, 2017
Non Small Cell Lung Cancer Trial in Worldwide (Pemetrexed, Cisplatin, Etoposide)
Non Small Cell Lung Cancer Patients Treated With Erlotinib Six
Completed
- Non Small Cell Lung Cancer
-
Nashville, TennesseeTennessee Oncology, PLLC
Mar 4, 2016
Non Small Cell Lung Cancer Trial in United States (Pazopanib, Erlotinib)
Completed
- Non Small Cell Lung Cancer
-
Fort Myers, Florida
- +7 more
Dec 22, 2015
Non Small Cell Lung Cancer Trial in United States (Pemetrexed, Bevacizumab, Carboplatin)
Non Small Cell Lung Cancer Trial in Worldwide (eribulin mesylate, pemetrexed, Eribulin mesylate (eribulin; E7389))
Unknown status
- Non Small Cell Lung Cancer
- eribulin mesylate
- +2 more
-
Tucson, Arizona
- +17 more
Jan 23, 2015
Non Small Cell Lung Cancer Trial in United States (STA 9090)
Completed
- Non Small Cell Lung Cancer
- STA 9090
-
Tucson, Arizona
- +20 more
Sep 18, 2014
Non Small Cell Lung Cancer Trial in Worldwide (IPI 504 plus Docetaxel, Placebo plus Docetaxel)
Completed
- Non Small Cell Lung Cancer
- IPI 504 plus Docetaxel
- Placebo plus Docetaxel
-
Chandler, Arizona
- +65 more
May 16, 2014
Non Small Cell Lung Cancer Trial in Worldwide (Mapatumumab, Paclitaxel, Carboplatin)
Completed
- Non Small Cell Lung Cancer
- Mapatumumab
- +2 more
-
Birmingham, Alabama
- +32 more
Aug 1, 2013
Non Small Cell Lung Cancer Trial in United States (Talactoferrin, Placebo)
Unknown status
- Non Small Cell Lung Cancer
- Talactoferrin
- Placebo
-
Duarte, California
- +5 more
Mar 13, 2012